GN
Genomma Lab Internacional, S.A.B. de C.V.
GNMLF · OTC
$0.77 +7.18% (+$0.05)
1M -6.09%
Market Cap 12.9B $
P/E Ratio 7.97x
Div. Yield 5.76%
ROE 14.23%
Bulios Fair Price
$1.02
32.4% upside
Trenutna cena
$0.77
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica GNMLF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
94 /100
Cheap EV/EBITDA 4.85x
P/S 0.76x
P/B 1.10x
Growth
27 /100
Declining Rev. growth 1.19%
FCF growth 12.43%
Book val. growth 2.83%
Profitability
69 /100
Strong Net margin 9.52%
Op. margin 20.62%
FCF margin 4.71%
Quality
64 /100
Average ROE 14.23%
ROA 6.70%
Asset turnover 0.70x
Debt
66 /100
Moderate Current ratio 1.41x
Int. coverage 3.06x
Net debt/EBITDA 1.43x
Stability
67 /100
Stable Rev. volatility 8.56%
EPS volatility 25.45%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o GNMLF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Juan Marco Sparvieri
Employees
1,465
Headquarters
Mexico City
Prihajajoči dogodki
21 OKT.
Earnings
Upcoming earnings report